Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,967
Closed -$502K 668
2023
Q1
$502K Buy
3,967
+143
+4% +$17.3K 0.04% 345
2022
Q4
$415K Sell
3,824
-247
-6% -$21.8K 0.03% 394
2022
Q3
$280K Buy
+4,071
New +$283K 0.02% 482
2022
Q2
Sell
-4,127
Closed -$315K 589
2022
Q1
$315K Buy
4,127
+637
+18% +$60.3K 0.02% 492
2021
Q4
$408K Sell
3,490
-146
-4% -$22.5K 0.04% 386
2021
Q3
$513K Buy
3,636
+146
+4% +$20K 0.04% 356
2021
Q2
$408K Sell
3,490
-1,159
-25% -$114K 0.04% 387
2021
Q1
$379K Sell
4,649
-205
-4% -$15.6K 0.04% 341
2020
Q4
$304K Buy
+4,854
New +$277K 0.04% 317
2018
Q4
Sell
-22
Closed 463
2018
Q3
$0 Buy
+22
New +$423 ﹤0.01% 1142

Other funds holding CROX

Csenge Advisory Group's CROX Position: Q2 2023 in Review

Csenge Advisory Group sold out of Crocs (CROX) in Q2 2023, closing a stake of 3,967 shares — an estimated $502K sold.

Csenge Advisory Group first reported a position in CROX in Q3 2018 and held it in 10 quarters. The position peaked at $513K in Q3 2021. 478 funds tracked by Wall St. Rank hold CROX as of Q2 2023.

  • Csenge Advisory Group reported no remaining Crocs position as of Q2 2023 after selling out during the quarter.
  • Csenge Advisory Group sold 3,967 Crocs shares in Q2 2023, an estimated $502K.
  • Csenge Advisory Group first reported a position in Crocs in Q3 2018 and held it in 10 quarters.
  • Csenge Advisory Group's Crocs position peaked at $513K in Q3 2021.
  • 478 funds tracked by Wall St. Rank held Crocs as of Q2 2023.

Based on Csenge Advisory Group's 13F filing for Q2 2023, filed 20 Jul 2023.